Page last updated: 2024-09-05

yttrium ethylenediaminetetra(methylenephosphonic acid) and organophosphonates

yttrium ethylenediaminetetra(methylenephosphonic acid) has been researched along with organophosphonates in 6 studies

Compound Research Comparison

Studies
(yttrium ethylenediaminetetra(methylenephosphonic acid))
Trials
(yttrium ethylenediaminetetra(methylenephosphonic acid))
Recent Studies (post-2010)
(yttrium ethylenediaminetetra(methylenephosphonic acid))
Studies
(organophosphonates)
Trials
(organophosphonates)
Recent Studies (post-2010) (organophosphonates)
6019,9688803,596

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beaney, RP; Keeling, AA1
Beaney, RP; Keeling, AA; Vaughan, AT1
Oberhausen, E; Schaefer, A1
Braun, U; Herzog, H; Müller-Gärtner, HW; Neumaier, B; Plag, C; Rösch, F; Stöcklin, G1
Dudczak, R; Eidherr, H; Ettlinger, D; Kletter, K; Kluger, R; Mien, LK; Mitterhauser, M; Toegel, S; Viernstein, H; Wadsak, W1
Ahmad, M; Jehangir, M; Perveen, A; Sohaib, M1

Other Studies

6 other study(ies) available for yttrium ethylenediaminetetra(methylenephosphonic acid) and organophosphonates

ArticleYear
Yttrium-87 for in vivo imaging.
    International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1991, Volume: 18, Issue:2

    Topics: Animals; Mice; Mice, Inbred BALB C; Organometallic Compounds; Organophosphonates; Organophosphorus Compounds; Tissue Distribution; Yttrium Radioisotopes

1991
Yttrium-90-EDTMP: a radiotherapeutic agent in the treatment of leukaemias.
    British journal of cancer, 1989, Volume: 60, Issue:1

    Topics: Animals; Bone and Bones; Leukemia, Experimental; Male; Mice; Mice, Inbred BALB C; Organometallic Compounds; Organophosphonates; Organophosphorus Compounds; Pentetic Acid; Tissue Distribution; Yttrium Radioisotopes

1989
[Performance of a multispect 2 gamma camera for imaging 511-keV gamma rays].
    Nuklearmedizin. Nuclear medicine, 1995, Volume: 34, Issue:1

    Topics: Deoxyglucose; Electrons; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Rays; Humans; Models, Structural; Neoplasms; Nitrilotriacetic Acid; Organometallic Compounds; Organophosphonates; Organophosphorus Compounds; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon

1995
Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomography.
    European journal of nuclear medicine, 1996, Volume: 23, Issue:8

    Topics: Aged; Aged, 80 and over; Bone Marrow; Bone Neoplasms; Citrates; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphonates; Palliative Care; Prostatic Neoplasms; Radiotherapy Dosage; Tomography, Emission-Computed; Yttrium Radioisotopes

1996
In vitro evaluation of no carrier added, carrier added and cross-complexed [90Y]-EDTMP provides evidence for a novel "foreign carrier theory".
    Nuclear medicine and biology, 2006, Volume: 33, Issue:1

    Topics: Bone and Bones; Drug Carriers; Evidence-Based Medicine; Humans; In Vitro Techniques; Organometallic Compounds; Organophosphonates; Protein Binding; Yttrium Radioisotopes

2006
Ethylene diamine tetramethylene phosphonic acid labeled with various β(-)-emitting radiometals: labeling optimization and animal biodistribution.
    Cancer biotherapy & radiopharmaceuticals, 2011, Volume: 26, Issue:2

    Topics: Animals; Beta Particles; Bone and Bones; Bone Marrow; Isotope Labeling; Male; Metals, Rare Earth; Organometallic Compounds; Organophosphonates; Organophosphorus Compounds; Pain; Palliative Care; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tissue Distribution

2011